Kimberly Reed of Takeda (NYSE: TAK) details shares, RSUs and tax awards

Rhea-AI Filing Summary

Takeda Pharmaceutical Co. Ltd. director Kimberly A. Reed filed an initial beneficial ownership report showing a mix of share holdings and equity awards. She reports direct holdings of 9,700 Ordinary Shares and 8,975 American Depositary Shares. The filing also lists several Tax Obligation Awards, each economically equivalent to one Ordinary Share, covering 1,152, 1,192 and 1,180 underlying Ordinary Shares with vesting and expiration dates on June 1 of 2026, 2027 and 2028. Footnotes explain that separate restricted stock unit awards will vest in tranches of 3,100, 3,400 and 3,200 Ordinary Shares on those same dates, with each RSU converting into one Ordinary Share and then into an equivalent number of American Depositary Shares following vest.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Reed Kimberly A.

(Last) (First) (Middle)

C/O MOMENTUS INC.

3050 KENNETH ST.

(Street)

SANTA CLARA CALIFORNIA 95054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	9,700(1)	D
American Depositary Shares	8,975	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Tax Obligation Award	06/01/2026	06/01/2026	Ordinary Shares	1,152	(2)	D
Tax Obligation Award	06/01/2027	06/01/2027	Ordinary Shares	1,192	(2)	D
Tax Obligation Award	06/01/2028	06/01/2028	Ordinary Shares	1,180	(2)	D

Explanation of Responses:

1. Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 ordinary shares), June 1, 2027 (3,400 ordinary shares) and June 1, 2028 (3,200 ordinary shares).

2. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Remarks:

Exhibit 24 Power of Attorney

	/s/ Max Heuer, by power of attorney, for Kimberly Reed	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What did Kimberly A. Reed report in her Form 3 for TAK?

Kimberly A. Reed reported her initial beneficial ownership in Takeda, including 9,700 Ordinary Shares, 8,975 American Depositary Shares, and multiple equity-based awards tied to future vesting and tax obligations across several years.

How many Takeda ordinary shares does Kimberly Reed hold directly?

The filing shows Kimberly Reed directly holding 9,700 Ordinary Shares of Takeda Pharmaceutical. This figure reflects her beneficial ownership as of the report date and sits alongside additional equity awards that may convert into shares or cash over time.

How many American Depositary Shares of TAK does Kimberly Reed report?

Kimberly Reed reports direct ownership of 8,975 American Depositary Shares of Takeda. These ADS holdings are in addition to her Ordinary Share position and her various restricted stock unit and Tax Obligation Award interests tied to future vesting dates.

What are the Tax Obligation Awards disclosed for Takeda (TAK)?

The Tax Obligation Awards are instruments economically equivalent to one Ordinary Share each. Upon vesting, they convert into cash payments primarily to cover tax obligations at the then-current Ordinary Share market price, rather than delivering additional shares to the reporting person.

What RSU vesting schedule is disclosed for Takeda director Kimberly Reed?

The report describes restricted stock units vesting in three tranches: 3,100 Ordinary Shares on June 1, 2026, 3,400 on June 1, 2027, and 3,200 on June 1, 2028. Each RSU converts into one Ordinary Share, then into an equivalent number of American Depositary Shares.

Does the TAK Form 3 show any insider buying or selling by Kimberly Reed?

The Form 3 primarily lists existing holdings and equity awards with unknown transaction codes, not explicit open-market purchases or sales. It functions as an initial ownership snapshot rather than a record of new buy or sell transactions in Takeda securities.